Static vs. Dynamic Progressive Splinting for Persistent Wrist Stiffness After DRF
Static-Progressive Versus Dynamic Low-Load Orthosis Strategies for Persistent Wrist Stiffness After Distal Radius Fracture: A Two-Arm, Parallel-Group, Assessor-Blinded, Superiority Randomized Controlled Trial
This two-arm, parallel-group, assessor-blinded, superiority randomized controlled trial compares two complete orthotic strategies for adults aged 18 to 65 years with persistent wrist stiffness at least 8 weeks after an operatively or nonoperatively managed distal radius fracture (DRF). Participants are randomized 1:1 to an optimized static-progressive orthosis strategy (repeated 30-minute end-range stress-relaxation sessions, progressing to three sessions per day) or an optimized dynamic low-load orthosis strategy (prolonged low-load stretch, target at least 6 hours per day). Both strategies are added to an identical standardized rehabilitation program of one 45-minute supervised session per week for 6 weeks plus the same home-exercise program.
Before randomization, each participant's index restricted direction (wrist flexion or extension) is fixed using a deterministic algorithm based on the ratio of affected to contralateral passive range of motion (PROM). The single confirmatory primary outcome is index-direction wrist PROM (degrees) measured by goniometry 6 weeks after randomization. It is analyzed under intention-to-treat as the baseline-adjusted mean between-group difference. Secondary outcomes include index-direction active range of motion (AROM), opposite-direction and sagittal-arc PROM/AROM, Patient-Rated Wrist Evaluation (PRWE) scores, patient satisfaction, orthosis wear-time adherence, treatment burden and resource use, formal adverse events, and transient tolerability events, assessed at baseline, 6 weeks, and 3 months.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Cairo Governorate
-
Cairo, Cairo Governorate, Egypt, 12311
- Faculty of Physical Therapy, Al Hayah University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 to 65 years at the time of consent.
- Isolated distal radius fracture managed operatively or nonoperatively.
- At least 8 weeks since fracture and medically cleared for progressive wrist stretching.
- Persistent wrist stiffness: affected-wrist PROM in flexion and/or extension of 50% or less of the corresponding contralateral PROM at screening.
- Documented prior rehabilitation exposure (date active wrist rehabilitation began, number of supervised visits, home-program exposure, immobilization duration).
- Contralateral wrist suitable as a reference: no previous major fracture or surgery, neurological disorder, inflammatory arthropathy, or other condition materially limiting flexion or extension.
- Able to use the assigned orthosis independently or with reliable caregiver assistance and to complete daily adherence logs.
- Able to provide written informed consent.
Exclusion Criteria:
- Complex regional pain syndrome (Budapest criteria) or suspected CRPS requiring alternative management.
- Active fracture-healing concern, unstable fixation, nonunion or malunion awaiting a surgical decision, active infection, or open wound incompatible with orthosis use.
- Clinically important median, ulnar, or radial nerve symptoms aggravated by stretching or orthosis compression.
- Skin disease or allergy preventing safe orthosis wear.
- Major wrist pathology unrelated to the fracture, or a contralateral wrist disorder that invalidates the reference measurement.
- Concurrent treatment plan requiring another stretching orthosis during the 6-week intervention.
- Any medical or cognitive condition preventing safe adherence to the home orthosis program.
- Pregnancy or breastfeeding.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Static Progressive Splinting Group (SPSG)
A static-progressive turnbuckle wrist orthosis targets the prespecified index restricted direction for 6 weeks: one 30-minute session per day in Week 1, two per day in Week 2, and three per day in Weeks 3 to 6. Participants may re-tension every 5 minutes to restore a strong but tolerable stretch. This is added to the standardized rehabilitation program (one 45-minute supervised session per week plus a home-exercise program) that is identical in both arms. |
A commercially available static progressive splint with a turnbuckle mechanism allowing fine-tuned adjustments in wrist flexion and extension. Instructional materials for home use including written guidelines and an adjustment log. One supervised 45-minute session per week for 6 weeks, delivered from a fixed checklist. Content: active and active-assisted wrist flexion/extension and forearm rotation, hand and finger mobility, progressive grip and wrist strengthening, and functional task practice. Any manual stretching or mobilization uses a fixed dose that is identical in both arms. The same written home-exercise program is provided to both arms. Orthosis fitting time is logged separately. |
|
Experimental: Dynamic Splinting Group (DSG)
A spring-loaded dynamic wrist orthosis targets the prespecified index restricted direction for 6 weeks, with a target of at least 6 hours per day of cumulative wear after a standardized acclimation period. Tension is set by the therapist and reviewed weekly; participants do not self-escalate. |
One supervised 45-minute session per week for 6 weeks, delivered from a fixed checklist. Content: active and active-assisted wrist flexion/extension and forearm rotation, hand and finger mobility, progressive grip and wrist strengthening, and functional task practice. Any manual stretching or mobilization uses a fixed dose that is identical in both arms. The same written home-exercise program is provided to both arms. Orthosis fitting time is logged separately. Materials: A commercially available dynamic (spring-loaded) splint designed for the wrist. An instructional manual and daily usage log for participants. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wrist Active and Passive Range of Motion (AROM/PROM)
Time Frame: Assessed at baseline, 6 weeks (post-intervention), and 3 months follow-up.
|
Measured using a standard goniometer, improvements in wrist flexion and extension (in degrees) are the primary indicators of treatment efficacy. |
Assessed at baseline, 6 weeks (post-intervention), and 3 months follow-up.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient-Rated Wrist Evaluation (PRWE)
Time Frame: Assessed at baseline and at 6 weeks post-intervention.
|
The PRWE questionnaire assesses wrist pain and disability, with lower scores indicating better functional status. |
Assessed at baseline and at 6 weeks post-intervention.
|
|
Patient Satisfaction
Time Frame: Collected at 6 weeks and 3 months post-intervention.
|
A standardized satisfaction survey measuring patients' perceived improvement and overall satisfaction with the orthotic intervention. |
Collected at 6 weeks and 3 months post-intervention.
|
|
Incidence of Adverse Events
Time Frame: Continuously monitored from baseline to the 3-month follow-up.
|
Incidence and severity of adverse events such as skin breakdown, discomfort, or pain (≥4/10) associated with splint usage. |
Continuously monitored from baseline to the 3-month follow-up.
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- SPDS2025-03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.